Drug Pipeline Quarterly Update: December 2020

Drugs in review, drugs with expiring patents, generic availability and more.

December 30, 2020

These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.

December 2020 Quarterly Traditional Pipeline Update
December 2020 Quarterly Specialty Pipeline Update

Related news

Perspectives

June 1, 2023

Prime reimagines patient care, unites care team for a better experience and smarter treatment plan

The patient journey from a cancer diagnosis through treatment with multiple specialty medications…

Perspectives

May 30, 2023

Specialty Drug Pipeline Update: May 2023

This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…

Perspectives

May 30, 2023

Traditional Drug Pipeline Update: May 2023

This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…